pharma · Community Acquired Pneumonia
Nabriva Therapeutics
Nabriva Therapeutics Ireland DAC
Nabriva Therapeutics Ireland is a pharma organization headquartered in IE. Primary therapeutic focus areas include Community Acquired Pneumonia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent
IE HQ
2006 Founded
25 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- IE
- Founded
- 2006
- Employees
- 25
- Programs
- 1
- Drugs
- 1
- Patents
- 0
lefamulin
Phase 3 · small molecule · Community Acquired Pneumonia
lefamulin for Community Acquired Pneumonia is a Phase 3 program (small_molecule) at Nabriva Therapeutics Ireland DAC with 1 ClinicalTrials.gov record(s).
Internal code NAB-BC-3781-3102
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nabriva Therapeutics Ireland DAC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Community Acquired Pneumonia
- Status
- completed
- Trials
- 1